News

Enter your email address to get Core One Labs News Alerts.
Company News
May 06, 2021
Core One Labs Commences Development on Patent Pending Psychedelic Drug Formulation for the Treatment of Alzheimer’s Disease
Vancouver, British Columbia, Canada – May 6, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”)...
Read more
Company News
May 05, 2021
World Renowned Physician Joins Core One Labs as Chief Medical Officer
Vancouver, British Columbia, Canada – May 5, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”)...
Read more
Company News
May 04, 2021
Core One Labs Unaware of Any Material Change that Would Account for Significant Share Price Depreciation
Vancouver, British Columbia, Canada – May 4, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”)...
Read more
Company News
May 04, 2021
Core One Labs Completes Milestone Acquisition of Akome Biotech
Vancouver, British Columbia, Canada – May 4, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) a biotechnology research...
Read more
Company News
April 29, 2021
Core One Labs Appoints Patent Expert, Dr. Dan Polonenko, To Advisory Board
Vancouver, British Columbia, Canada – April 29, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce it has appointed...
Read more
Company News
April 29, 2021
Core One Labs Reaches Definitive Agreement to Acquire Akome Biotech
Vancouver, British Columbia, Canada – April 29, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”), a biotechnology research...
Read more